Current national trend of using two access points to put newborns in respiratory failure on ECMO increases mortality

Feb. 15, 2022

The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, rather than a single cannula in the right internal jugular, increases mortality rates for these babies, reported by Augusta University.

Extracorporeal membrane oxygenation (ECMO) is a machine that treats critically ill infants and children by acting as an artificial heart-lung bypass. It provides oxygen to a patient's blood and can be used for a period of days, or weeks, to give organs a chance to develop, heal and recover. 

Their assessment of nearly 250 newborns placed on ECMO because of respiratory failure over 17 years indicates that when breathing, not heart function, is the problem, the safest path is a single cannula in the right internal jugular that can remove oxygen-poor blood from the baby, run it through the ECMO circuit to clean it and add oxygen, then put it back into the baby at the same site, according to ECMO team members at Children’s Hospital of Georgia and the Medical College of Georgia.

“If your heart is not working correctly and your lungs are not working correctly, then we can bypass the whole system. But if the baby’s heart is working correctly, I think you have to ask, should we not be using it,” says Dr. Brian Stansfield, neonatologist at MCG and CHOG and vice chair for research in the MCG Department of Pediatrics.

The dual access veno-arterial approach just incurs greater risk, says Dr. Jessica Gancar, neonatology fellow at MCG and CHOG, for reasons like it  does not enable clot filtering, which increases the risk for brain bleeds and strokes. “You also are putting a big IV in a major artery and that comes with unwanted risk because ultimately the natural function for that artery is to supply oxygenated blood to your brain,” Stansfield says.

They looked at 244 newborns placed on ECMO for respiratory failure from 2002-19 at CHOG, the pediatric teaching hospital for MCG, Georgia’s public medical school. They looked at the babies’ demographics and medical records to determine which cannula approach was used, as well as outcome and predicted mortality risk based on a risk assessment for babies requiring ECMO called Neo-RESCUERS.

The group had a 93% overall survival and 71% of the babies had a single cannula placed in the right internal jugular in an approach called veno-venus. The right internal jugular is the largest vein in the neck and collects oxygen poor blood from the head and neck, including the brain.

The cannula pulls the oxygen-poor blood right before it goes into the heart, runs it through the ECMO circuit which replenishes the oxygen as the lungs normally would, then puts the now oxygen-rich blood back into the same cannula and vein so it can resume its normal path to the heart, which ultimately pumps the blood back out to the head and neck.

The remainder of the newborns had two cannulas placed, with the second in the right common carotid artery, which runs essentially parallel to the right internal jugular. This veno-arterial approach bypasses both the heart and lungs and directly puts oxygen-rich blood back into the arterial system to supply the head and neck with oxygenated blood.

They found the mortality rate for babies in respiratory failure put on ECMO with the veno-arterial approach was 17% versus 2.7% with veno-venus. They also found that the total hours spent on ECMO was not directly associated with mortality risk.

But the national trend for putting newborns in respiratory failure on ECMO is to use veno-arterial about 80% of the time, even when heart function is sound, a trend the ECMO team at MCG and CHOG doesn’t follow or understand.

In Augusta, the team basically does the exact opposite; in fact, they continue to whittle away at the percentages of babies on whom they use the veno-arterial approach, reserving it, for example, when they have concerns that a baby’s heart function cannot sustain the baby on ECMO.

Gancar, one of the next generation of neonatologists, hopes the message to her colleagues across the nation is to opt for veno-venous ECMO when heart function is good to eliminate some mortality risk and have better outcomes.

Augusta University release